Veraxa Biotech AG - Post de-SPAC
Disclosed SEC business address
TALACKER 35, ZURICH, 8001
Veraxa Biotech AG - Post de-SPAC (ticker VRXAW, CIK 0002079109) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Every item is grounded on the cited public source — no figures are fabricated.
Go deeper
This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 4 free company deep views left this month.
Sources
- U.S. Securities and Exchange Commission, EDGAR · filing index · retrieved 2026-10-20T00:15:58.534676+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing index · retrieved 2026-11-03T06:52:17.255132+00:00
- SEC EDGAR · issuer filing index
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.